See the rest here: Caladrius Biosciences to Present at the 13th Annual LD Micro Main Event Conference
See the rest here: Caladrius Biosciences to Present at the 13th Annual LD Micro Main Event Conference
The rest is here: NGM Discloses Third Oncology Development Candidate, NGM438, a Novel Antagonist Antibody Inhibiting LAIR1 for the Treatment of Advanced Solid Tumors
Read more: Immutep Reports Statistically Significant Survival Benefit for Key Patient Groups in the Ongoing Phase IIb AIPAC Study in Metastatic Breast Cancer
Continue reading here: G1 Therapeutics Presents Final Phase 2 Clinical Data on Trilaciclib in Combination with Chemotherapy in Metastatic Triple-Negative Breast Cancer...
View original post here: ARCA biopharma Announces Location Change for 2020 Annual Meeting of Stockholders
View post: Immutep’s Chinese Partner EOC Pharma to Start Phase II Metastatic Breast Cancer Study
See more here: IBEX Reports Results for the First Quarter Ended October 31, 2020
More here: Nurix Therapeutics Presents Preclinical Data at 62nd American Society of Hematology (ASH) Annual Meeting and Exposition
Read this article: Cellworks CBM Identifies Genomic Signatures Impacting HOXA Regulation that Determine Response for AML Patients with Monosomy 7
Read the original: TG Therapeutics Announces Pivotal Data from the UNITY-CLL and UNITY-NHL Clinical Trials Presented at the 62nd American Society of Hematology Annual...
Recent Comments